Steve Sosnick, Interactive Brokers’ chief strategist, discusses the latest vaccine news from Astra-Zeneca and Oxford University.
With each new vaccine development, the stock market dynamics are changing, according to Sosnick. Here’s why:
Photo Credit: Yuri Samoilov via Flickr Creative Commons
The stock market digested November’s robust gains for much of last week but rallied strongly amid falling bond yields on the last trading day.
Are storm clouds gathering on the horizon?
The S&P 500 and Nasdaq indexes were under pressure to start the week as the AI trade and tech more broadly came under scrutiny. Then markets flattened out as the week wrapped up.
The U.S. budget deficit, which has been a point of discussion among economists and investors, recently received a downgrade in credit rating from Fitch Ratings agency, citing expected fiscal deterioration, a high and growing general government debt burden, and erosion of governance.
